Literature DB >> 6839006

Kinetics of cocaine in humans after intravenous and intranasal administration.

J I Javaid, M N Musa, M Fischman, C R Schuster, J M Davis.   

Abstract

Cocaine kinetics were studied in four subjects after intravenous and intranasal administration. For intravenous administration cocaine hydrochloride (32 mg) dissolved in physiological saline was injected in 1 ml volume over a 1 min period. Intranasal cocaine was administered as 100 mg powder consisting of an appropriate dose of cocaine hydrochloride (64 and 96 mg) mixed with lactose powder. Subjects were instructed to inhale the mixture through a 5 cm straw within 1 min. Cocaine kinetics, after intravenous injection, conform to a one-compartment open model with first-order elimination. After intranasal administration, cocaine kinetics conform to a one-compartment model with first-order absorption and first-order elimination. The mean half-life of cocaine for intravenous injection in four subjects was 41.4 +/- 8.2 min (mean +/- S.E.M.) and the range was 19 to 64 min. There were statistically significant differences in the mean area under the concentration-time curve (AUC) following intravenous and intranasal administration. The AUC was dose-dependent and the fraction of the dose absorbed after 64 mg intranasal cocaine was significantly lower than after 96 mg dose (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6839006     DOI: 10.1002/bdd.2510040104

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  18 in total

Review 1.  Pharmacokinetics of cocaine in pregnancy and effects on fetal maturation.

Authors:  R C Wiggins
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

Review 2.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

4.  Revisiting a physiologically based pharmacokinetic model for cocaine with a forensic scope.

Authors:  María Elena Bravo-Gómez; Laura Nayeli Camacho-García; Luz Alejandra Castillo-Alanís; Miguel Ángel Mendoza-Meléndez; Alejandra Quijano-Mateos
Journal:  Toxicol Res (Camb)       Date:  2019-03-13       Impact factor: 3.524

Review 5.  Cocaine and crack.

Authors:  J Strang; G Edwards
Journal:  BMJ       Date:  1989-08-05

Review 6.  Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date.

Authors:  Mary R Lee; Lorenzo Leggio
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

Review 7.  Testing for drugs of abuse. Pharmacokinetic considerations for cocaine in urine.

Authors:  J Osterloh
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

8.  Bioavailability and Pharmacokinetics of Oral Cocaine in Humans.

Authors:  Marion A Coe; Rebecca A Jufer Phipps; Edward J Cone; Sharon L Walsh
Journal:  J Anal Toxicol       Date:  2018-06-01       Impact factor: 3.367

9.  Behavioral responses during the initial exposures to a low dose of cocaine in late preweanling and adult rats.

Authors:  Kiersten S Smith; Joan I Morrell
Journal:  Neurotoxicol Teratol       Date:  2008-01-19       Impact factor: 3.763

10.  Relationship between the discriminative stimulus effects and plasma concentrations of intramuscular cocaine in rhesus monkeys.

Authors:  X Lamas; S S Negus; E Hall; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.